Depressed patients less likely to complete cardiac rehab

February 15, 2013
Depressed patients less likely to complete cardiac rehab
Depressed patients are less likely to complete exercise-based, cardiac rehabilitation programs, regardless of whether they are taking antidepressants, according to a study published in the Feb. 1 issue of The American Journal of Cardiology.

(HealthDay)—Depressed patients are less likely to complete exercise-based, cardiac rehabilitation programs, regardless of whether they are taking antidepressants, according to a study published in the Feb. 1 issue of The American Journal of Cardiology.

Neil F. Gordon, M.D., Ph.D., from INTERVENT International in Savannah, Ga., and colleagues analyzed data from 26,957 patients who had completed a baseline assessment before participating in a 12-week exercise-based . Based on baseline self-reported history of depression and the current use of antidepressants, patients were stratified into three cohorts: non-depressed, depressed unmedicated, and depressed medicated).

The researchers found that 19.2 percent of patients self-reported a history of depression at baseline, with 41.5 percent of these patients taking antidepressants. Patients in the non-depressed cohort were significantly more likely to complete the exit assessment than patients in the depressed unmedicated or the depressed medicated cohorts (49.4 percent completion versus 44.5 and 43.5 percent, respectively). In all three cohorts, significant improvements were noted in multiple risk factors for those who completed the exit assessment. The magnitude of improvement was similar in measures of blood pressure, serum lipids and lipoproteins, fasting glucose, weight, and for patients taking antidepressants and those who were not.

"Given the high prevalence of depression and the compelling evidence that it substantially increases the risk of events, the present data have important implications for physicians and payers of ," the authors write. "Specifically, our findings serve to further highlight the need to optimize secondary prevention program referral, participation, and compliance for patients with a history of depression, including those treated with antidepressants."

Several authors disclosed financial ties to INTERVENT, a lifestyle management and chronic disease risk reduction company.

Explore further: Antidepressants -- not depression -- increase risk of preterm birth, study shows

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Antidepressants -- not depression -- increase risk of preterm birth, study shows

May 28, 2012
(Medical Xpress) -- Women who are depressed during pregnancy are not at higher risk of giving birth prematurely than non-depressed women — but those who take antidepressants during pregnancy seem to be, a new study ...

Hepatitis C drug can cause depression

May 1, 2012
There's a high rate of depression among patients with hepatitis C, but a standard treatment for the disease includes a drug, interferon, that can cause depression.

Ibuprofen, aspirin, other anti-inflammatory drugs reduce effectiveness of SSRI antidepressants

April 25, 2011
Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, ...

Study suggests link between untreated depression and response to shingles vaccine

February 14, 2013
Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine. Older adults are known ...

Statins linked with lower depression risk in heart patients

February 24, 2012
Patients with heart disease who took cholesterol-lowering statins were significantly less likely to develop depression than those who did not, in a study by Mary Whooley, MD, a physician at the San Francisco VA Medical Center ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.